JCRB1192 KMS-28BM
Cell information
Cell type:general cells (View Pricing Information)
JCRB No. | JCRB1192 | Cell Name | KMS-28BM |
---|---|---|---|
Profile | human myeloma cell line. | Other Name | |
Animal | human | Strain | |
Genus | Homo | Species | sapiens |
Sex | F | Age | 77 |
Identity | available | Tissue for Primary Cancer | hemo-lymphocytic |
Case history | Metastasis | Yes | |
Tissue Metastasized | Genetics | t(4;14)(p16.3;q32.3) | |
Life Span | infinite | Crisis PDL | |
Morphology | lymphocyte-like | Character | small round-cell morphology, part is multinucleate cell. |
Classify | tumor | Established by | Otsuki, T. |
Registered by | Otsuki, T. | Regulation for Distribution | |
Comment | Year | 2006 | |
Medium | RPMI1640 medium with 10% fetal bovine serum. | Methods for Passages | Subculture twice a week by dilution(1/10). |
Cell Number on Passage | 50000 cells / mL | Race | Japanese |
CO2 Conc. | Tissue Sampling | bone marrow | |
Tissue Type | myeloma(IgGλ) |
Detection of virus genome fragment by Real-time PCR | |||||||||
---|---|---|---|---|---|---|---|---|---|
Detected DNA Virus | tested | Detected RNA Virus | tested | ||||||
CMV | - | parvoB19 | - | HCV | - | HTLV-1 | - | ||
EBV | - | HBV | - | HIV-1 | - | HTLV-2 | - | ||
HHV6 | - | HTLV-1 | - | HIV-2 | - | HAV | - | ||
HHV7 | - | HTLV-2 | - |
-/negative. +/positive. nt/not tested. (positive (+) does not immediately mean the production of infectious viral particles.) |
|||||
BKV | - | HIV-1 | - | ||||||
JCV | - | HIV-2 | - | ||||||
ADV | - | HPV18 | - | ||||||
Notes |
Reference | |
---|---|
Pubmed id:15491288 | Expression of protein gene product 9.5 (PGP9.5)/ubiquitin-C-terminal hydrolase 1 (UCHL-1) in human myeloma cells. Otsuki T,Yata K,Takata-Tomokuni A,Hyodoh F,Miura Y,Sakaguchi H,Hatayama T,Hatada S,Tsujioka T,Sato Y,Murakami H,Sadahira Y,Sugihara T Br J Haematol. 2004 Nov;127(3):292-8 |
Pubmed id:11886382 | Interleukin 10 abolishes the growth inhibitory effects of all-trans retinoic acid on human myeloma cells. Otsuki T,Yata K,Sakaguchi H,Kurebayashi J,Matsuo Y,Uno M,Fujii T,Eda S,Isozaki Y,Yawata Y,Yamada O,Wada H,Sugihara T,Ueki A Br J Haematol. 2002 Mar;116(4):787-95 |
Images |
---|
LOT Information
Cell No. | JCRB1192 | Cell Name | |
---|---|---|---|
LOT No. | 10212011 | Lot Specification | distribution |
Medium | RPMI 1640 medium with 10% fetal bovine serum (FBS, GIBCO Cat. # 10099) | Temperature | 37 C |
Cell Density at Seeding | 2 - 5 x 10^5 cells/mL | Methods for Passages | Simple dilution |
Doubling Time | approx. 38 hrs. | Cell Number in Vial (cells/1ml) | 3.3 x 10^6 |
Viability at cell freezing (%) | 89.3 | Antibiotics Used | free |
Passage Number | Unknown (6 at bank) | PDL | |
Sterility: MYCOPLASMA | - | Sterility: BACTERIA | - |
Sterility: FUNGI | - | Isozyme Analysis | Confirmed as human by NP, G6PD (type B), MD. |
Chromosome Mode | Chromosome Information | ||
Surface Antigen | DNA Profile (STR) | ||
Adhesion | Yes | Exoteric Gene | |
Medium for Freezing | 10% DMSO, 20% FBS - RPMI 1640 | CO2 Conc. | 5% |
Viability immediately after thawing (%) | Additional information |
Cell No. | JCRB1192 | Cell Name | |
---|---|---|---|
LOT No. | 11042009 | Lot Specification | distribution |
Medium | RPMI 1640 medium with heat-inactivated fetal bovine serum (GIBCO Cat. # 10099) | Temperature | 37 C |
Cell Density at Seeding | 4.9 - 7.2 x 10^5 cells/ml | Methods for Passages | Simple dilution. |
Doubling Time | approx. 53 hrs | Cell Number in Vial (cells/1ml) | 9.7 x 10^6 |
Viability at cell freezing (%) | 89.7 | Antibiotics Used | free |
Passage Number | Unknown (5 at bank) | PDL | |
Sterility: MYCOPLASMA | - | Sterility: BACTERIA | - |
Sterility: FUNGI | - | Isozyme Analysis | Confirmed as human by NP, G6PD (type B), MD. |
Chromosome Mode | Chromosome Information | ||
Surface Antigen | DNA Profile (STR) | ||
Adhesion | No | Exoteric Gene | |
Medium for Freezing | 10% DMSO, 20% FBS - RPMI 1640 | CO2 Conc. | 5% |
Viability immediately after thawing (%) | Additional information |
Cell No. | JCRB1192 | Cell Name | KMS-28BM |
---|---|---|---|
LOT No. | 04032007 | Lot Specification | distribution |
Medium | RPMI1640(GIBCO) with 10% heat inactivated fetal bovine serum(Hyclone GRD0051) | Temperature | 37 C |
Cell Density at Seeding | 3.5x10^5 cells/ml | Methods for Passages | subculture by dilution(pipetting or scraping) |
Doubling Time | NT | Cell Number in Vial (cells/1ml) | 4.1x10^6 |
Viability at cell freezing (%) | 84.4 | Antibiotics Used | free |
Passage Number | p2* | PDL | NT |
Sterility: MYCOPLASMA | - | Sterility: BACTERIA | - |
Sterility: FUNGI | - | Isozyme Analysis | NT |
Chromosome Mode | NT | Chromosome Information | NT |
Surface Antigen | NT | DNA Profile (STR) | D5S818:14 D13S317:11 D7S820:8,11 D16S539:9,11 VWA:17 TH01:7,9.3 AM:X TPOX:8,9 CSF1PO:10 |
Adhesion | No | Exoteric Gene | NT |
Medium for Freezing | Cell Banker:BLC-1(Nihon Zenyaku Industries) | CO2 Conc. | 5 % |
Viability immediately after thawing (%) | Additional information |
Images |
---|
Cell No. | JCRB1192 | Cell Name | KMS-28BM |
---|---|---|---|
LOT No. | 03272020 | Lot Specification | distribution |
Medium | RPMI 1640 medium with heat-inactivated fetal bovine serum (FBS; Sigma Cat. # 172012) | Temperature | 37 C |
Cell Density at Seeding | approx. 2 x 10^5 cells/mL | Methods for Passages | Subculture by dilution. Cells will loosely attach to substratum. The cells were harvested by pipetting or scraping. |
Doubling Time | approx. 46 hrs. | Cell Number in Vial (cells/1ml) | 1.9 x 10^6 |
Viability at cell freezing (%) | 80.0 | Antibiotics Used | free |
Passage Number | Unknown (5 at bank) | PDL | |
Sterility: MYCOPLASMA | - | Sterility: BACTERIA | - |
Sterility: FUNGI | - | Isozyme Analysis | |
Chromosome Mode | Chromosome Information | ||
Surface Antigen | DNA Profile (STR) | ||
Adhesion | Yes | Exoteric Gene | |
Medium for Freezing | 10% DMSO, 20% FBS - RPMI 1640 | CO2 Conc. | 5% |
Viability immediately after thawing (%) | 73.7 | Additional information |